Latest Stock Split Details
Key information about Hemogenyx Pharmaceuticals Plc's most recent stock split
Split Date: 2024-12-13
Split Ratio: 1:400
Price Before Split: $0.00
Price After Split: $0.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 400.00 times fewer shares (a 1:400 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Hemogenyx Pharmaceuticals Plc's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-12-13 | 1:400 | Yes | $0.00 | $0.00 |
About Hemogenyx Pharmaceuticals Plc
Company overview and industry information
Hemogenyx Pharmaceuticals Plc (HOPHF) operates in the Biotechnology industry. The recent 1-for-400 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Hemogenyx Pharmaceuticals Plc Summary